HCV burden of infection in Egypt: results from a nationwide survey.
about
A review of the infection-associated cancers in North African countriesHepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-AnalysisHepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent dataHepatitis C genotype 4: The past, present, and futureThe Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-AnalysisBest strategies for global HCV eradication.Hepatitis C Virus in North Africa: An Emerging ThreatPrior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virusSchistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patientsAssessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin TreatmentCross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in Qatar.Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection.Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.The genetic diversity and evolutionary history of hepatitis C virus in VietnamSpatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications.Prioritizing High-Risk Practices and Exploring New Emerging Ones Associated With Hepatitis C Virus Infection in Egypt.Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients.A major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report.Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors.Health Research and Millennium Development Goals: Identifying the Gap From Public Health Perspective.Viral transmission risk factors in an Egyptian population with high hepatitis C prevalenceLow-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in EgyptPegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection.Female Genital Cutting and Hepatitis C Spread in EgyptDiagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patientsThe Value of U/S to Determine Priority for Upper Gastrointestinal Endoscopy in Emergency Room.Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based surveyPolymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection.The Association between Female Genital Cutting and Spousal HCV Infection in Egypt.Hepatitis C virus infection in the Maghreb region.HCV transmission in industrialized countries and resource-constrained areas.Acute hepatitis C: management in the rapidly evolving world of HCV.Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis.Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
P2860
Q26741909-48595285-202B-4756-94C9-E2E5ED0F20E4Q26768490-3F27BB1B-BDE9-4232-B2D6-BF5C89EC7825Q26773191-6B27EFC3-7738-457A-9956-4E4A8551B1E2Q26775815-2182DAF4-408B-4A9A-B151-B749BBAA1EEBQ26795711-E99FB821-4A39-4921-96D6-72976E9D9FBAQ27693824-8F2B1267-1D37-4417-8C6C-6E1C1FB45579Q28069590-A8BBC98E-5B25-4BD3-8352-47BD316E9EBEQ30881190-0BC4F408-82FF-46A5-B96D-6E399C371636Q31066011-CF6FFFE2-C3FC-468B-91C2-D858A2B49483Q33588479-D7641266-EFE9-4C9D-B212-ED1D0E85FC3CQ33625258-6DDC834C-09EB-4156-A170-593C79C796A5Q33826033-DCD3AAB8-2272-452F-9F90-60D8F81A2FB7Q34008754-35E45420-CFE4-4E7A-B3C3-3FC158614776Q34470975-57237B39-227B-40FE-98E4-843467C2B1FFQ34608134-F1D4CE36-6544-40CE-A30F-AD1E83819709Q34612510-C9954921-406F-4AD9-8EA3-96490D0776FEQ34615527-7FD1BB25-47C4-41A5-A286-E5B1BE3C1AB9Q34806261-BA80169B-2DE5-4961-A8F4-3DE5D71F9216Q35639127-6BD96A8A-A641-4067-A29B-08B3319FDFD5Q35666697-9EAFE0CE-5DE5-4482-A97E-EFCBC72618CCQ35800572-826C6B94-F862-420C-BF09-1A7965BEF239Q35837823-92B3E57E-94BC-405F-A486-F3A96E779D04Q35864882-7303B285-19C6-4CDF-A362-1DC32A995376Q36131126-ABDE4928-EA16-4DE0-914C-78232907E573Q36168072-16E8ACAC-C828-4D5E-8953-AE42DEAE7508Q36256411-3B83C497-2007-4900-830E-C0D9D22A6034Q36263107-B9A818F0-D333-4311-8371-1C831E56CDBBQ36961945-2F8A734E-6BD2-4B63-9844-8E412CB9555BQ37212664-81E1E41F-35D4-4DBA-9137-2436A9DED67DQ37226053-FC84C86F-171E-4C39-936D-6ECD37D7B790Q37334134-426FF72B-9EB5-4A7D-97E1-858A2BB29993Q37485037-99F9E458-0567-435A-A1D9-1E248A0770A1Q37689986-1CBF1128-9023-43C2-899D-AAB741A5A43AQ37693859-3590B2DC-C722-4483-8F4E-23339B521BF2Q38115493-DE1BB3F6-6608-4EE1-BE03-130DC8E3CCC5Q38147886-CA161C4C-A6F7-4A2D-9A6F-0B0B91465A72Q38183312-7F4FC415-6FBF-4F1D-A330-7F16776A25E2Q38459012-7855F84A-8A67-4A29-A34D-D01846484BBAQ38610365-EA53F299-034F-42DE-BADF-175126E33C34Q38855568-9BDE706C-A624-4FB9-B166-F67635F945BE
P2860
HCV burden of infection in Egypt: results from a nationwide survey.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HCV burden of infection in Egypt: results from a nationwide survey.
@en
HCV burden of infection in Egypt: results from a nationwide survey.
@nl
type
label
HCV burden of infection in Egypt: results from a nationwide survey.
@en
HCV burden of infection in Egypt: results from a nationwide survey.
@nl
prefLabel
HCV burden of infection in Egypt: results from a nationwide survey.
@en
HCV burden of infection in Egypt: results from a nationwide survey.
@nl
P2093
P2860
P1476
HCV burden of infection in Egypt: results from a nationwide survey.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2011.01576.X
P577
2012-02-06T00:00:00Z